[{"type": "title", "data": "OB Antepartum Hemorrhage Admission and Management (Version 2.32)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "For patients less than 30 weeks gestation or where there is a significant maternal risk, consider antepartum transport to a tertiary care center, if feasible "}, {"type": "note", "data": "Admit To Obstetrics Regular Bed Telemetry Bed required : No Patient Diagnosis: Antepartum Hemorrhage"}, {"type": "order", "data": "Admit to", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Transmission Precautions", "value": ""}, {"type": "note", "data": "For patients at increased risk of preterm birth, avoid the routine use of activity limitation to prevent preterm delivery "}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, q2hr"}, {"type": "sentence", "data": "T;N, q4hr"}, {"type": "sentence", "data": "T;N, q6hr"}, {"type": "sentence", "data": "T;N, q8hr"}, {"type": "order", "data": "CBGM", "value": ""}, {"type": "sentence", "data": "T;N, qAM, Before breakfast and 2 hours after meals"}, {"type": "sentence", "data": "QIDAC&amp;HS, 30 minutes AC meals and prior to HS snack."}, {"type": "order", "data": "Notify Provider", "value": ""}, {"type": "sentence", "data": "If blood glucose is &lt; 3.5 mmol/L or &gt; 10 mmol/L"}, {"type": "order", "data": "Intermittent Fetal Heart Auscultation (IA)", "value": ""}, {"type": "sentence", "data": "As per SOGC Fetal Health Surveillance: Antepartum and Intrapartum Consensus Guideline"}, {"type": "order", "data": "Fetal Heart Monitoring External", "value": ""}, {"type": "sentence", "data": "As per SOGC Fetal Health Surveillance: Antepartum and Intrapartum Consensus Guideline"}, {"type": "order", "data": "Fetal Heart Monitoring Via Scalp Electrodes (FECG)", "value": ""}, {"type": "sentence", "data": "As per SOGC Fetal Health Surveillance: Antepartum and Intrapartum Consensus Guideline"}, {"type": "note", "data": "For patients in labor with nonreassuring fetal heart rate patterns, consider the use of maternal oxygen supplementation. For patients in labor, avoid prophylactic use of continuous maternal oxygen supplementation to prevent nonreassuring fetal status."}, {"type": "order", "data": "Oxygen Therapy (O2)", "value": ""}, {"type": "sentence", "data": "Constant Order, PRN Order, If abnormal or atypical fetal heart rate patterns"}, {"type": "order", "data": "Notify Provider", "value": ""}, {"type": "order", "data": "Fetal Heart Monitoring External", "value": ""}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Activity as Tolerated (AAT)", "value": "checked"}, {"type": "order", "data": "Bedrest (BR)", "value": "checked"}, {"type": "sentence", "data": "T;N, Constant Order"}, {"type": "sentence", "data": "T;N, Constant Order, With bathroom privileges"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "Regular Diet", "value": ""}, {"type": "order", "data": "Diabetic Diet", "value": ""}, {"type": "order", "data": "NPO", "value": ""}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Lactated Ringers Bolus", "value": ""}, {"type": "sentence", "data": "500 mL, IV BOLUS, Injection, Once, NOW"}, {"type": "order", "data": "Sodium Chloride 0.9% Bolus", "value": ""}, {"type": "sentence", "data": "500 mL, IV BOLUS, Injection, Once, NOW"}, {"type": "order", "data": "Sodium Chloride 0.9% intravenous solution", "value": ""}, {"type": "sentence", "data": "1,000, IV, T;N, 180 day(s), mL/hr"}, {"type": "sentence", "data": "1,000, IV, T;N, 180 day(s), 100 mL/hr"}, {"type": "order", "data": "Lactated Ringers intravenous solution", "value": ""}, {"type": "sentence", "data": "1,000, IV, T;N, 180 day(s), mL/hr"}, {"type": "sentence", "data": "1,000, IV, 180 day(s), 100 mL/hr"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "<P>GBS Prophylaxis</P><P>-For patients with group B streptococcal (GBS) colonization, OR at 24 to 36+6 weeks of gestation with unknown GBS status: provide antibiotic prophylaxis, regardless of prior antibiotic treatment</P>"}, {"type": "note", "data": "<P><A href=&quot;file://\\\\Chorioamnionitis&quot;>Chorioamnionitis</A> should be considered when any of the following signs or symptoms are noted: </P><P>- Maternal fever ( &amp;gt; 38.0 degrees Celsius) </P><P>- Maternal leukocytosis ( &amp;gt; 15,000 cells/mm2) </P><P>- Maternal tachycardia ( &amp;gt; 100 bpm) </P><P>- Fetal tachycardia ( &amp;gt;160 bpm) </P><P>- Uterine tenderness </P><P>- Foul smelling vaginal discharge </P>"}, {"type": "note", "data": "Corticosteroids- For patients between 23 and 34+6 weeks of gestation with intact membranes who are at risk of preterm delivery within 7 days, administer a course of betamethasone or dexamethasone "}, {"type": "order", "data": "betamethasone", "value": ""}, {"type": "sentence", "data": "12 mg, IM, Injection, q24hr(sched), NOW, 2 dose(s), Unless delivery occurs prior"}, {"type": "order", "data": "dexamethasone", "value": ""}, {"type": "sentence", "data": "6 mg, IM, Injection, q12hr(sched), NOW, 4 dose(s), Unless delivery occurs prior"}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "325 mg, PO, Caplet, q4hr, PRN, Pain / Temperature, 180 day(s)"}, {"type": "sentence", "data": "650 mg, PO, Caplet, q4hr, PRN, Pain / Temperature, 180 day(s)"}, {"type": "order", "data": "morphine", "value": ""}, {"type": "sentence", "data": "5 mg, IM, Injection, q4hr, PRN, Pain, 5 day(s)"}, {"type": "sentence", "data": "10 mg, IM, Injection, q4hr, PRN, Pain, 5 day(s)"}, {"type": "order", "data": "morphine 10 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "5 mg, IV Piggyback, Injection, q4hr, PRN, Pain"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "25 mg, PO, Tab, q4hr, PRN, Nausea or Vomiting"}, {"type": "sentence", "data": "50 mg, PO, Tab, q4hr, PRN, Nausea or Vomiting"}, {"type": "order", "data": "dimenhyDRINATE 50 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "25 mg, IM, Injection, q4hr, PRN, Nausea, 180 day(s)"}, {"type": "sentence", "data": "50 mg, IM, Injection, q4hr, PRN, Nausea, 180 day(s)"}, {"type": "order", "data": "dimenhyDRINATE 50 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "25 mg, IV, Injection, q4hr, PRN, Nausea, 180 day(s)"}, {"type": "sentence", "data": "50 mg, IV, Injection, q4hr, PRN, Nausea, 180 day(s)"}, {"type": "order", "data": "PEG 3350 Powder", "value": ""}, {"type": "sentence", "data": "17 g, PO, Powder Recon, Daily, 180 day(s)"}, {"type": "sentence", "data": "17 g, PO, Powder Recon, BID, 180 day(s)"}, {"type": "order", "data": "Hold Medication(s)", "value": ""}, {"type": "sentence", "data": "Hold PEG if patient has diarrhea (ie. loose stools, or more than 3 BMs a day) Restart when diarrhea is resolved."}, {"type": "order", "data": "RHo (D) immune globulin 1500 intl units/1.3 mL injectable solution", "value": ""}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC w/ Diff", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "note", "data": "NH Order to be configured: Kleihauer Stain STAT Blood"}, {"type": "note", "data": "<P><FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>See&nbsp;Blood Products: Make Available and Transfuse PowerPlan for packed red blood cell transfusion</FONT></P>"}, {"type": "order", "data": "Group B Strep Culture", "value": ""}, {"type": "sentence", "data": "Vag/Rectal, STAT collect, T;N"}, {"type": "order", "data": "History Check", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "ABO/D Typing", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "Antibody Screen", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "Crossmatch", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "Product Request", "value": "checked"}, {"type": "sentence", "data": "STAT collect"}, {"type": "order", "data": "RhIG Eligibility", "value": ""}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "US Biophysical Profile Non Stress", "value": ""}, {"type": "sentence", "data": "T;N, P1 &lt; 24 hours"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Consult to Endocrinology", "value": ""}, {"type": "sentence", "data": "AntepartumPatient on insu"}, {"type": "order", "data": "Consult to Pediatrics", "value": ""}, {"type": "sentence", "data": "Parental counselling re:"}, {"type": "category", "data": "Communication Orders"}, {"type": "order", "data": "Notify Provider", "value": ""}]
